Literature DB >> 15848178

The characterization of plasma membrane Ca2+-ATPase in rich sphingomyelin-cholesterol domains.

Yuhong Pang1, Hua Zhu, Ping Wu, Jianwen Chen.   

Abstract

According to the raft hypothesis, sphingolipid-cholesterol (CHOL) microdomains are involved in numerous cellular functions. Here, we have prepared liposomes to simulate the lipid composition of rafts/caveolae using phosphatidylchone, sphingomyelin (SPM)-CHOL in vitro. Experiments of both 1,6-diphenyl-1,3,5-hexatriene and merocyanine-540 fluorescence showed that a phase transition from l(d) to l(o) can be observed clearly. In particular, we investigated the behavior of a membrane protein, plasma membrane Ca(2+)-ATPase (PMCA), in lipid rafts (l(o) phase). Three complementary approaches to characterize the physical appearance of PMCA were employed in the present study. Tryptophan intrinsic fluorescence increase, fluorescence quenching by both acrylamid and hypocrellin B decrease, and MIANS fluorescence decrease, indicate that the conformation of PMCA embedded in lipid l(o) phase is more compact than in lipid l(d) phase. Also, our results showed that PMCA activity decreased with the increase of SPM-CHOL content, in other words, with the increase of l(o) phase. This suggests that the specific domains containing high SPM-CHOL concentration are not a favorable place for PMCA activity. Finally, a possible explanation about PMCA molecules concentrated in caveolae/rafts was discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15848178     DOI: 10.1016/j.febslet.2005.03.038

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

Review 1.  Plasma-membrane Ca(2+) pumps: structural diversity as the basis for functional versatility.

Authors:  E E Strehler; A G Filoteo; J T Penniston; A J Caride
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

2.  Plasma membrane calcium pump activity is affected by the membrane protein concentration: evidence for the involvement of the actin cytoskeleton.

Authors:  Laura Vanagas; Rolando C Rossi; Ariel J Caride; Adelaida G Filoteo; Emanuel E Strehler; Juan Pablo F C Rossi
Journal:  Biochim Biophys Acta       Date:  2007-03-24

Review 3.  The plasma membrane calcium pump: new ways to look at an old enzyme.

Authors:  Raffaele Lopreiato; Marta Giacomello; Ernesto Carafoli
Journal:  J Biol Chem       Date:  2014-02-25       Impact factor: 5.157

4.  Rapid turnover of stereocilia membrane proteins: evidence from the trafficking and mobility of plasma membrane Ca(2+)-ATPase 2.

Authors:  M'hamed Grati; Mark E Schneider; Karen Lipkow; Emanuel E Strehler; Robert J Wenthold; Bechara Kachar
Journal:  J Neurosci       Date:  2006-06-07       Impact factor: 6.167

5.  Internalization of plasma membrane Ca2+-ATPase during Xenopus oocyte maturation.

Authors:  Wassim El-Jouni; Shirley Haun; Khaled Machaca
Journal:  Dev Biol       Date:  2008-09-18       Impact factor: 3.582

Review 6.  Lipid rafts/caveolae as microdomains of calcium signaling.

Authors:  Biswaranjan Pani; Brij B Singh
Journal:  Cell Calcium       Date:  2009-03-25       Impact factor: 6.817

7.  Structure of the human plasma membrane Ca2+-ATPase 1 in complex with its obligatory subunit neuroplastin.

Authors:  Deshun Gong; Ximin Chi; Kang Ren; Gaoxingyu Huang; Gewei Zhou; Nieng Yan; Jianlin Lei; Qiang Zhou
Journal:  Nat Commun       Date:  2018-09-06       Impact factor: 14.919

8.  Metabolic regulation of calcium pumps in pancreatic cancer: role of phosphofructokinase-fructose-bisphosphatase-3 (PFKFB3).

Authors:  D A Richardson; P Sritangos; A D James; A Sultan; J I E Bruce
Journal:  Cancer Metab       Date:  2020-04-02

9.  Plasma Membrane Calcium ATPase-Neuroplastin Complexes Are Selectively Stabilized in GM1-Containing Lipid Rafts.

Authors:  Katarina Ilic; Xiao Lin; Ayse Malci; Mario Stojanović; Borna Puljko; Marko Rožman; Željka Vukelić; Marija Heffer; Dirk Montag; Ronald L Schnaar; Svjetlana Kalanj-Bognar; Rodrigo Herrera-Molina; Kristina Mlinac-Jerkovic
Journal:  Int J Mol Sci       Date:  2021-12-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.